Clinical Study

Relation of High-Density Lipoprotein Cholesterol and Apoprotein A1 Levels with Presence and Severity of Coronary Obstruction

Table 1

Distribution of lipid parameters in Group 1 (patients presenting a ≥50% diameter stenosis in at least one major coronary artery) and Group 2 (patients who had no significant obstructions).

Group 1 ( 𝑛 = 6 5 9 )Group 2 ( 𝑛 = 2 3 9 ) 𝑃

Lipids (mg/dL)
 Total cholesterol182.84 (42.71)188.12 (41.65)NS
 HDLc44.35 (12.08)48.75 (13.30)0.001
 Triglycerides131.62 (90.43)123.45 (61.19)N.S.
 LDLc112.97 (36.40)115.27 (35.65)N.S.
 apoB99.94 (26.61)99.18 (26.10)N.S.
 apoA1132.37 (26.36)141.21 (25.71)0.001
 Non-HDLc138.69 (40.03)139.37 (39.67)N.S.
 Ratios
 CT/HDLc 4.36 (1.33)4.07 (1.17)0.005
 LDLc/HDLc 2.70 (1.07)2.49 (0.95)0.015
 apoB/apoA1 0.78 (0.25)0.73 (0.23)0.003

HDLc: high-density lipoprotein cholesterol; LDLc: low-density lipoprotein cholesterol; apo: apolipoprotein.
Parametric variables are expressed as mean (standard deviations); 𝑃 values for differences between the two groups were determined by Student’s 𝑡 -test.